// App-Quantinova.ai

e15591 : Platelet-to-hemoglobin ratio as a prognostic factor for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization.

Researchers

Presenter

  • Xing Li

Principal Investigators

  • Zhi-Huan Lin

  • Ying-fen Hong

  • Tian-tian Wang

  • Dong-hao Wu

  • Xiao-kun Ma

  • Yan-Fang Xing

  • Mingsheng Huang

  • Min Dong

  • Qu Lin

  • Xiang-yuan Wu

Medical Centers

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

  • Department of Nephrology, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final